Market cap
₹211 Cr
Recently Viewed
Clear AllNSE: INDOUS | BSE: 541304
₹104.27
₹0.16
(0.15%)
As on 30-Apr-2026IST
Market cap
₹211 Cr
Revenue (TTM)
₹118 Cr
P/E Ratio
14.2
P/B Ratio
2.3
Div. Yield
0.2 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹15 Cr
ROE
23 %
ROCE
21.1 %
Industry P/E
15.86
EV/EBITDA
12.8
Debt to Equity
0.2
Book Value
₹44.7
EPS
₹7.4
Face value
10
Shares outstanding
20,052,000
CFO
₹-7.18 Cr
EBITDA
₹63.06 Cr
Net Profit
₹48.55 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Indo Us Bio-Tech
| -14.2 | 3.2 | -20.7 | -32.6 | -- | -- | -- |
|
BSE FMCG
| -6.3 | 12.6 | 0.8 | -7.9 | 3.1 | 8.4 | 9.4 |
|
Company
|
2025
|
|---|---|
|
Indo Us Bio-Tech
| -59.4 |
|
BSE Small Cap
| -6.6 |
|
BSE FMCG
| -2.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Indo Us Bio-Tech
|
104.3 | 210.6 | 117.8 | 14.8 | 14.6 | 18 | 14.2 | 2.3 |
| 281.3 | 1,398.3 | 1,378.9 | 101.1 | 9.9 | 13.5 | 13.8 | 2.0 | |
| 166.0 | 3,440.7 | 1,463.4 | 73.6 | 6.1 | 16.3 | 46.8 | 6.6 | |
| 246.8 | 296.2 | 493.3 | 4.4 | 0.5 | 2.7 | 71.5 | 1.7 | |
| 965.4 | 4,960.0 | 1,377.9 | 300.8 | 20.1 | 18.3 | 16.5 | 2.7 | |
| 430.7 | 14,968.3 | 10,267.2 | 636.9 | 9.0 | 16.2 | 23 | 3.4 | |
| 4.7 | 501.1 | 1,440.2 | 343.1 | 24.1 | 32.2 | 1.5 | 0.4 | |
| 196.0 | 372.5 | 445.5 | 43.1 | 9.9 | 5.9 | 8.6 | 0.5 | |
| 268.2 | 297.7 | 14.1 | 1.1 | 7.5 | 18.1 | 281.4 | 43.2 | |
| 4.0 | 495.5 | 1,312.7 | 33.1 | 5.1 | 8.6 | 15 | 1.0 |
No Review & Analysis are available.
Manufacture of food products
Incorporated
2004
Chairman
--
Managing Director
Jagdish Ajudia
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Indo US Bio-Tech Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
The share price of Indo US Bio-Tech Ltd is ₹104.27 (NSE) and ₹105.00 (BSE) as of 30-Apr-2026 IST. Indo US Bio-Tech Ltd has given a return of -32.63% in the last 1 years.
The P/E ratio of Indo US Bio-Tech Ltd is 14.19 times as on 30-Apr-2026, a 11 discount to its peers’ median range of 15.86 times.
The P/B ratio of Indo US Bio-Tech Ltd is 2.35 times as on 30-Apr-2026, a 20 premium to its peers’ median range of 1.96 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
18.15
|
3.76
|
|
2024
|
53.94
|
7.09
|
|
2023
|
14.71
|
3.91
|
|
2022
|
12.22
|
1.61
|
|
2021
|
3.36
|
0.93
|
The 52-week high and low of Indo US Bio-Tech Ltd are Rs 206.00 and Rs 96.05 as of 30-Apr-2026.
Indo US Bio-Tech Ltd has a market capitalisation of ₹ 211 Cr as on 30-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Indo US Bio-Tech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.